Apigenin for ALS

Also known as: 4',5,7-trihydroxyflavone, Chamomile extract

Apigenin's NAD+ preservation and anti-inflammatory effects may support motor neuron survival in ALS.

Mechanism of Action

Apigenin's CD38 inhibition maintains NAD+ pools in motor neurons, supporting SIRT1/3-dependent mitochondrial protection. Its NF-κB inhibition reduces neuroinflammatory damage from activated microglia and astrocytes.

General mechanism: Flavone. CD38 inhibitor (NAD+ preservation), NF-κB suppressor, CK2/PI3K inhibitor, BDNF promoter.

Current Evidence

Preclinical neuroprotection data. CD38 as therapeutic target in ALS is emerging. No ALS-specific trials.

Clinical Status: Preclinical. Available as supplement.

Safety Profile

Very safe. Naturally present in diet. Sedative at high doses (chamomile effect). No significant drug interactions.

Key Research Questions

View glossary entry →

← Back to ALS Research